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Abstract: Background: Although research has examined patients’ perception of
quality of life while in opioid maintenance treatment, the focus has mainly been on
health-related quality of life. Objectives: This study aimed to investigate opioid
maintenance treatment patients’ subjective overall quality of life and the potential
association between quality of life and factors, such as housing, the relationship
with their partner, children and friends, leisure, work, financial situation and health
during the first year in treatment. Methods: Self-recruited first-time enrolled
patients met for a structured registration through face-to face interviews every third
month for 12 months. Sociodemographic factors and nine indicators of quality of
life from the National Quality Register for Substance Abuse Treatment were utilized.
Results: Participants (N = 38), reported a significant improvement in overall quality
of life in the first year F (1, 40.4880) = 7.532, p = .009, with a positive effect on
.19 per time unit. In particular, the domain financial situation predicted improved
quality of life, F (1, 37.774) = 14.212, p = .001. Moreover, there was no significant
change for subjective factors such as leisure, relationship with children, housing,
health, and relationship with a partner across time. Specific domains of quality of
life such as housing, leisure and financial situation were positively associated with
overall quality of life. Conclusions: These results suggest that to address factors as
a part of patients’ treatment can be instrumental in improving quality of life. Further
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research is needed to explore these findings in a larger opioid maintenance treat-
ment population.
Subjects: Social Sciences; Behavioral Sciences; Health and Social Care
Keywords: quality of life; opioid maintenance treatment; patient reported outcome
measures; patient reported experience measures; factors; financial situation; follow-up
Individuals with substance use disorders (SUD) experience harmful impacts and long-term impair-
ments in their lives such as mental and physical problems, issues related to social relationships,
housing and personal economy (McLellan, Lewis, O’Brien, & Kleber, 2000; Muller, Skurtveit, &
Clausen, 2017; Shion, Sambamoorthy, Ying, & Aznal, 2014; Tiffany, Friedman, Greenfield, Hasin, &
Jackson, 2012). SUD treatment emphasizes reduction in drug use, deemed successful when
patients test negative for drugs (Mitchell et al., 2015; Strada et al., 2017; Tiffany et al., 2012).
However, with a comprehensive perspective on SUD, abstinence is no longer the only goal (Bolek,
Yargic, & Ekinci, 2016; De Maeyer, Vanderplasschen, & Broekaert, 2010; Mitchell et al., 2015).
Although the increasing emphasis on patients’ empowerment and the interest in patients’ view-
point may present important insights into treatment and life in general, few studies utilize sub-
stance (ab)users’ perspectives as an important source of information (De Maeyer, van
Nieuwenhuizen, Bongers, Broekaert, & Vanderplasschen, 2013; Strada et al., 2017). Thus, the
concept of quality of life (QOL) is becoming increasingly important in the field of addiction research
(Mitchell et al., 2015; Rudolf & Watts, 2002; Strada et al., 2017).
The concept of QOL has been used inconsistently in different research fields (Gill & Feinstein,
1994; Laudet, Becker, & White, 2009; Zubaran & Foresti, 2009). Terms like life satisfaction, sub-
jective well-being and health-related quality of life (HRQOL) are sometimes used synonymously
with QOL (Camfield & Skevington, 2008; De Maeyer et al., 2010). Although there is no consensus on
the content of the term QOL, researchers agree that QOL is subjective and multidimensional (De
Maeyer et al., 2010; Laudet et al., 2009; WHO, 1995b). A widely used definition of QOL is “an
individual’s perception of their position in life in the context of the culture and value systems in
which they live and in relation to their goals, expectations, standards and concerns” (WHO, 1995b,
p. 1405).
A widely applied standard in addiction research has been the focus on how a disease affects
a person`s functioning. In this context the absence of disease is essential (De Maeyer et al., 2010;
Moons, 2004; Zubaran & Foresti, 2009). Today, a more comprehensive approach acknowledges
QOL as a reflection of how people perceive and react to different aspects of a person’s life (Gill &
Feinstein, 1994). Domain satisfaction is a judgement of a specific aspect of an individual’s life, and
life satisfaction and domain satisfaction are generally correlated (Pavot & Diener, 2008). To better
understand patients’ satisfaction with life overall, and to give attention to social aspects, it has
been suggested that the best patient reported outcome measure to use is QOL (De Maeyer et al.,
2010; Muller, 2017).
In relation to the SUD population, research has primarily been concerned with socially desirable
outcomes such as abstinence, reduced criminality and prostitution and health-related issues.
Research on opioid maintenance treatment (OMT) with a focus on QOL has primarily had a health-
related perspective (De Maeyer, Vanderplasschen, & Broekaert, 2009; De Maeyer et al., 2010;
Laudet, 2011; Muller, Skurtveit, & Clausen, 2016b). Research has also focused on the correlation
between addiction severity and QOL, has compared groups with and without dual diagnosis, and
has analysed the impact of methadone or buprenorphine on patients’ QOL (Zubaran & Foresti,
2009). Concerning health-related quality of life (HRQOL), research has documented significant
improvements in physical and psychological health components of QOL (Karow et al., 2011;
Mitchell et al., 2015; Nosyk et al., 2011; Padaiga, Subata, & Vanagas, 2007; Torrens et al., 1997;
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Tran et al., 2016). At a 12-month follow-up, improvements were reported in the realm of pain/
discomfort and anxiety/depression (Nosyk et al., 2011). On the other hand, symptoms of sleep
problems, pain and depression influence OMT patients’ quality of life and the ability to function
(Peles, Schreiber, & Adelson, 2006; Pud, Zlotnick, & Lawental, 2012). A recent study demonstrates
a significant negative correlation between high methadone dosage (> 90 mg/day) and QOL in
several domains, including the physical and psychological domains (Pedrero-Perez, 2017).
In comparison to the general population and patients with other chronic diseases, patients in
OMT report significantly poorer QOL (Best et al., 2013; De Maeyer et al., 2010; De Maeyer,
Vanderplasschen, Lammertyn et al., 2011; Laudet et al., 2009; Rudolf & Watts, 2002). A study of
549 Norwegian patients, including inpatients and outpatients in both opioid maintenance treat-
ment and medication-free treatment, found that about three-fourths reported their overall QOL to
be poor or very poor. Furthermore, the results showed that those who stated methadone/bupre-
norphine as their preferred substance were more likely to report neutral, good or very good QOL
rather than very poor QOL (Muller, Skurtveit, & Clausen, 2016a). Research shows that QOL improves
after starting OMT, especially during the first months of treatment (De Maeyer, Vanderplasschen,
Lammertyn et al., 2011; Feelemyer, Jarlais, Arasteh, Phillips, & Hagan, 2014). The positive effect of
QOL is often explained by improvements in health (Nosyk et al., 2011).
Social support is an important predictor of success in OMT (Chou et al., 2013; Khuong, Vu, Huynh,
& Thai, 2018; Laudet, Morgen, & White, 2006; Lin, Wu, & Detels, 2011). Ponizovsky et al. (2010)
found that the best predictor of QOL was social support from friends and significant others. A study
of 159 patients enrolled in methadone treatment for about a decade identified social relationships
and support, psychological well-being, employment, independence and a meaningful life as
important components of a good QOL (De Maeyer, Vanderplasschen, Camfield et al., 2011).
Other factors linked to improved QOL are a life less controlled by the addiction, fewer social issues
and a better relationship with family and friends. Health was rarely mentioned in this context
(Brekke, Vetlesen, Høiby, & Skeie, 2010). Muller (2017) found that 12 month after initiation of
treatment changes in general QOL were related to development in patients’ social network. Those
who expanded or maintained an abstinent network reported a greater increase in QOL. Merely
patients who remained in OMT one year after enrolment reported improved social quality of life.
One of the goals of OMT is to improve the QOL of opioid-dependent individuals (Norwegian
Directorate of Health, 2010). The way in which opioid-dependent individuals experience their daily
life is not well researched (De Maeyer et al., 2009; Pasareanu, Opsal, Vederhus, Kristensen, &
Clausen, 2015). It is important to utilize user-driven approaches to gain insights into aspects that
determine OMT individuals’ self-perceived QOL (De Maeyer, Vanderplasschen, Camfield et al.,
2011). Instruments for measuring QOL in opioid-dependent patients tend to focus on health-
related aspects (Strada et al., 2017). Health is important for OMT patients’ QOL. However, the
broader impact of opioid dependence calls for instruments that also incorporate how social and
material living conditions add to the understanding of QOL. Patients’ social and material living
conditions have an impact on their overall QOL. On this background, our study addresses the
following aims:
(a) to examine patients’ overall QOL during the first year after enrolment in OMT, and
(b) to investigate potential correlations with overall QOL to domain-specific QOL indicators in
housing, relationship with children and friends, work, leisure, health and financial situation.
1. Material and methods
1.1. Sample
Participants for this study were recruited from eight OMT outpatient units in the catchment area of
Haukeland University Hospital, Bergen, Norway. The geographic catchment area includes
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approximately 350 000 inhabitants from Bergen municipality and surrounding municipalities.
There are about 1000 OMT patients in the catchment area of Haukeland University Hospital,
including patients who have been in OMT from 1998 to newly enrolled patients.
The National Quality Register for Substance Abuse Treatment (NQR-SAT) applies to individuals
with substance use disorders enrolled in treatment. NQR-SAT originates from western Norway and
is awaiting approval as a national registry. The initially established registry was used in the present
study.
Data used in this paper were collected from 47 self-recruited patients in OMT. They were
recruited during two periods: January to December 2013, and September 2015 to June 2016.
Inclusion criteria were opioid dependence according to ICD-10 or DSM-IV, age > 18 years, first time
admittances to OMT, living in Haukeland University Hospitals’ catchment area, and commence-
ment of OMT medication (Buprenorphine or Methadone) before the first registration. Lack of
competence to consent was the only exclusion criterion.
Patients received either buprenorphine or methadone as medical treatment with a variation in
dosage from 4 mg to 20 mg buprenorphine and 80 to 100 mg methadone. Two participants
received extended-release injections with naltrexone which blocks the effects of opioids. The
majority of patients came to their local outpatient unit for daily medication and a short conversa-
tion with the employee at the outpatient unit, while those in prison received medicine on a daily
basis from health employees in prison or prison staff. The two patients who received naltrexone
got a muscle injection once a month.
During the first year, five participants dropped out, three withdrew from the study due to lack of
interest, and one was excluded due to cognitive impairment and inability to provide consent. Data
from these participants were included in the analysis up to the time they completed the research
participation. The total sample included 47 opioid-dependent individuals’, 11 females and 36
males. For sociodemographic characteristics see (Carlsen & Torsheim, 2019).
1.2. Data collection
Participants met for structured registrations through face-to-face interviews every third month for
a period of two years. The current study utilizes data from baseline (T0) and every third month
through the first 12-month follow-up from T1 to T4. In total, 291 observations of a total of 47
individuals were analysed and distributed as follows: 47 participants at T0, 38 participants at T1
and T2, 34 participants at T3 and 36 at T4. Of the 47 included participants, 29 participants
completed all registrations, eight completed four, one completed three, four completed two, and
five participants completed only baseline registrations.
The principal investigator was responsible for data management. Participants provided written
informed consent to participate in the study, and the study was approved by the Regional
Committee for Medical and Health Research Ethics (2013/429/REK South-East C).
1.3. Measures
NQR-SAT collects Patient Reported Outcome Measures (PROM- data) and Patient Reported
Experience Measure (PREM-data). PROMs capture a patient’s perception of their health (self-
reported health status, symptoms, QOL, etc.) (Black, 2013; Neale et al., 2016; SKDE, 2017), whereas
PREMs capture a patient’s perception of their experience with health care or treatment (involve-
ment, communication, service access, etc. (SKDE, 2017). In other words, data in NQR-SAT are
patients’ subjective perceptions on given topics.
Questions from validated tools are incorporated in NQR-SAT, and nine indicators of QOL were
utilized in this study. One indicator measured the overall QOL, and eight indicators measured QOL
in specific social domains. To measure the overall QOL, we used the question “How would you rate
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your quality of life as a whole?”, which is used in several instruments on QOL, including WHOQOL-
Brief and WHOQOL (WHO, 1995a, 1996) and Personal Wellbeing Index (Cummins, Eckersley,
Pallant, van Vugt, & Misajon, 2003). The eight specific indicators reflect on various social life
domains, where some of them are strongly related to global life satisfaction (Tomyn,
Tyszkiewicz, & Cummins, 2011). The specific domain questions were: “How satisfied are you with:
1) your personal relationship with partner, 2) your relationship with children, 3) your relationship
with friends (International Wellbeing Group, 2013; Tomyn et al., 2011; WHO, 1996) 4) housing
(WHO, 1995a, 1996) 5) your health (International Wellbeing Group, 2013; WHO, 1996) 6) work
(WHO, 1995a) 7) leisure (WHO, 1995a), and 8) financial situation (WHO, 1995a). Equally to the
WHO-BRIEF (WHO, 1996) the participants reported, their QOL on a five-point Likert-type response
scale, ranging from 1 = “very dissatisfied” to 5 = “very satisfied” at each measurement point.
To measure participants drug use the NQR-SAT uses the question “How many days have you
used alcohol or drugs during the last 30 days?” which is the same question as in EuropASI (Blacken
et al., 1994).
1.4. Data analysis
Descriptive statistics with frequency analysis were used to examine the participants’ demographic
characteristics at baseline.
Linear mixed models for repeated measures were used to estimate level and change in
general and specific domains of QOL from baseline to 12-month follow up. Main and inter-
active effects were tested with Satterthwaite’s corrected F-test. A significance level of
p < 0.05 was considered statistically significant in all the analyses. SPSS version 24 was
used for the analysis.
The linear mixed analysis was conducted in two stages. The objective of the first stage was to
establish a proper model of change, regressing the dependent variable on time and relevant group
factors. In the random part of the model, we compared a random intercept only model with
a random intercept and random slope of time model. In the random intercept model, individuals
differed with respect to their intercept at time 0, but shared the effect of time. In the random
intercept and slope model, individuals differed in their intercept on time and in their slope of
change. Model fits were compared using likelihood ratio tests for nested models.
In the second stage of analysis, time invariant baseline factors were included to test differences
in intercept and change. Significance was assessed by omnibus F-tests per factor term. In addition,
we tested whether the effect of time interacted with baseline characteristics such as level of
education (no education/primary/secondary school/high school/higher education), marital status
(single/married), and type of living situation (own apartment/permanently with parents/temporary




There was attrition from baseline to follow-up. In the first year, eight participants missed one data
point, one participant missed two data points, four participants missed three data points, and five
participants missed four data points and had only baseline registration. Twenty-nine participants
had no missing values.
An independent sample t-test showed no significant differences for the first year between non-
completers and completers for level of education, marital status, and type of living situation. There
were no statistically significant differences at baseline between completers and non-completers
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with respect to quality of life in the domains of relationship with a partner, children and friends,
housing, health, work, leisure, and financial situation.
2.2. Demographic characteristics at T0
At baseline, the mean age of the 47 participants was 37.8 years, 76.6 % were men, and 93.6 %
were of Norwegian ethnicity. Among women who participated at baseline 73 % participated in the
follow-ups, while the average was 79 % among men. Approximately 50 % (n = 24) lived in their
own apartment, while 29.8 % (n = 14) had temporary housing such as rehabilitation homes,
treatment institutions or prison facilities. Seventy-six point six percent (n = 36) were single.
Primary/secondary school were reported as the participants’ highest level of education during
the entire 12-month follow-up. Fifty-eight percent (n = 22) had a meaningful activity at baseline,
yet none of the participants had work. Twenty-five participants had children, and 80 % (n = 20) of
them had visitation rights or custody of their own children under the age of 18 years, while 16 %
(n = 4) had no custody/visitation rights, and 28 % (n = 7) had adult children. At baseline, 63.8 %
(n = 30) had no unresolved issues with the police or justice system.
2.3. Change in QOL
Table 1 shows that the results form a series of linear mixed models regressing QOL on time. The
overall QOL increased significantly during the 12 months in OMT, F (1, 40.880) = 7.532, p = .009. The
positive effect of the overall QOL was b = .19 per time unit, corresponding to a moderate effect size
of 0.62 SD change during the 12 months. The random intercept and slope components were
statistically significant, indicating that patients differed in their level at baseline, as well as in
their rate of change. To exemplify, according to the effect of time, patients with a change rate at 2
SD below the mean change rate would have a decline in QOL, whereas patients with a change rate
at 2 SD above the mean would increase their overall QOL across time.
The rate of change for the first 12 months was positive for all specific QOL domains, except for
leisure, see Figure 1. Statistical significance of change per time unit was only achieved for financial
QOL F (1, 37.774) = 14.212, p = .001. At baseline, the average patients were dissatisfied with their
financial QOL and the increase per time unit was b = .18. A significant variation between patients
was also identified.
Based on few observations for QOL in relation to partner, relationship with children and work,
these domains were excluded from this analysis.There was no significant rate of change for friends
F (1, 38.542) = 1.488, p = .230, housing F (1, 38.847) = 7.33, p = .385 and health F (1,
37.014) = 3.140, p = .085. Participants did vary on the abovementioned domain-specific QOL and
spread across the entire scale. However, this variation was not significant.
In the last sequence of models, overall QOL was regressed on QOL in specific domains, using
specific QOL as time-varying covariates, see Table 2. QOL domains such as financial situation,
housing and leisure were associated with higher overall QOL. Leisure was the strongest contributor
b = .32, p = .001, followed by housing b = .22, p = .001 and financial situation b = .15, p = .03.
We also tested for interaction effect for level of education, marital status and type of housing.
None of these had any significant prediction on overall QOL, F (4, 43.822) = 1.103, p = .367,
F (2,104.367) = .413, p = .662, F (3, 94.529) = 1.670, p = .179, respectively.
3. Discussion
Patients are generally dissatisfied with their overall QOL before enrolling into OMT (De Maeyer,
Vanderplasschen, Lammertyn et al., 2011). Our main finding was that, although OMT patients QOL
fluctuated, on average their overall QOL improved after starting OMT, corresponding to a moderate
effect size. This result is congruent with previous research. The continuous positive improvement in
overall QOL can indicate that the gap between what patients expect and what they receive from
OMT is little.
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Different aspects can influence patients’ QOL. Giacomuzzi et al. (2003) found a significant
increase of QOL score for finances at six months follow-up. In the current study, participant’s
satisfaction with their financial situation was a significant predictor for positive overall QOL.
Norwegian OMT patients experience an immediate effect of the enrolment; they do not pay for
their OMT medication as this is covered by the welfare state. This releases capital that
previously was linked to purchase of opioids and other substances (Redden, Tracy, & Shafer,
2013). When starting in OMT, patients are given an opportunity to address the economic
challenges and utilize official help from the Norwegian Labour and Welfare Administration
(NAV). NAV assists patients with several issues, e.g. ensuring that bills are paid, setting up
a budget for debt repayment, and applying for social benefits or disability pension. Many OMT
patients have little regular work experience and do not have a regular income. By applying for
social benefits or disability pension, those who meet the requirements will receive a fixed
monthly income from the welfare state. By achieving control over their financial situation,
patients can achieve a security that they have not previously experienced, which can result in
economic freedom: they might have the opportunity to save money and/or buy things they





















Figure 1. Measures of QOL dur-
ing the 12- month follow-up
period (T1-T4)
Table 2. Overall QOL regressed on specific QOL social domains






Intercept 0.37 0.35 109.799 1.045 0.298 −0.33 1.07
Time 0.16 0.05 139.787 3.065 0.003 0.05 0.27
Housing 0.22 0.06 126.255 3.369 0.001 0.09 0.35
Leisure 0.32 0.08 143.819 4.013 0.001 0.16 0.48
Friends 0.00 0.06 137.011 0.000 1.000 −0.13 0.13
Health 0.07 0.07 120.643 1.025 0.307 −0.06 0.21
Financial 0.15 0.07 94.529 2.105 0.038 0.00 0.30
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About 68.6 % of the patients with five to ten years in outpatient methadone treatment
reported low QOL scores for financial situation (De Maeyer, Vanderplasschen, Lammertyn et al.,
2011). In our study, we also found that the average level of satisfaction with financial QOL was
low at baseline, yet it increased during the first 12 months. Some patients are heavily in debt
and live in an economic chaos, spending all their money and not being able to pay rent for
housing or other bills (Carlsen, Gaulen, Alpers, & Fjaereide, 2018; Gaulen, Alpers, Carlsen, &
Nesvåg, 2017). Losing contact and status in the drug environment can lead to a worse eco-
nomic situation, e.g. possible loss of income from illegal activity and less access to income.
Many patients emphasized the importance of having basic comforts such as affordable hous-
ing, money for personal transportation, food and an income (De Maeyer et al., 2009) never-
theless, living on disability benefits, for many, means that they must live on an existence
minimum.
By achieving financial security, housing, family, and basic comforts, OMT patients achieve
a stability in life and thereby a meaningful life (De Maeyer, Vanderplasschen, Camfield et al.,
2011). To improve QOL it is important to support OMT patients in their daily life with practical,
social and environmental support (De Maeyer, Vanderplasschen, Camfield et al., 2011). In this
context, leisure time is important. Engagement in meaningful activity has been associated with
better QOL (Best et al., 2012), and our findings show an association between high QOL leisure and
high overall QOL. Having something to do, an activity or interest, gives life meaning and purpose
and may reduce the loneliness many OMT patients’ experience and remove it as a prominently
negative factor.
Social network and relationship to family and friends have been highlighted as important
predictors for QOL (De Maeyer et al., 2009; De Maeyer, Vanderplasschen, Camfield et al., 2011;
Muller et al., 2017). Sun et al. (2015) found that family relations among patients, and the quality of
such relations, improved after starting OMT. Others have demonstrated that gaining an abstinent
social network improved the global QOL (Best et al., 2012; Muller et al., 2017). In our study, no
domains such as friends, partner or children were significant predictors for overall QOL. A possible
explanation for the discrepancy between previous research and our study may be that participants
experience loss of network and a social arena. Starting in OMT may be a new beginning for many
patients, a possibility to break with drug-using friends and the drug users’ network. Sun et al.
(2015) found that OMT patients reduced daily contact with drug-using friends after starting in OMT.
However, establishing a new drug-free network, or reconnecting with family members or old
friends, may take longer or occur later than during the first 12 months (Karow et al., 2011).
Other explanations can be that participants in our study were satisfied or dissatisfied with their
friends both before and after enrolling in OMT; the friends were still the same, and enrollment in
OMT did not change the friendship. Or, participants experienced themselves unable to establish
a drug-free network, or they wanted to wait to reconnect with drug-free friends until they were
back on their feet. Participants also reported that they had few or no friends in the drug environ-
ment, but many acquaintances. Lack of social network support, few friends and little or no contact
with family members are also factors demonstrated to be common in older patients in OMT
(Carlsen et al., 2018).
There is a significant time effect in the domains of general well-being (Winklbaur, Jagsch,
Ebner, Thau, & Fischer, 2008). Research has documented an increase in satisfaction with life
for patients during the first months in OMT (Maremmani, Pani, Pacini, & Perugi, 2007; Xiao,
Wu, Luo, & Wei, 2010), or during the first half-year (Karow et al., 2011; Padaiga et al., 2007).
Our study is in line with previous research regarding the effect of time on overall QOL.
Moreover, we found the effect to be present even twelve months after participants were
enrolled in OMT. Muller et al. (2017) showed that for those still in OMT, social QOL increased
during 12-month follow-up, and the increase was a function of treatment retention, not
a function of time.
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The present study did not incorporate the perspective of health on QOL. There is vast
evidence about the relationship between QOL and health (Fei, Yee, Habil, & Danaee, 2016;
Karow et al., 2010; Mitchell et al., 2015), and more research on the association between
social and material living conditions and QOL is needed. Besides, our study showed that
health was not significant, even though it was close to the significance level of .05. This
finding is not in line with the literature which states that health improves upon OMT entry.
There may be several reasons why health was not significant. One explanation may be that
the Norwegian welfare system ensures everyone equal treatment in the health care system
regardless of the status as OMT patient or not. Another possibility is that participants have
underreported both physical and mental ailments. Some participants did not agree with
diagnoses given them earlier in life, and chose therefore not to report these. Others did not
enter treatment in a very poor health condition, nor did they consider health as an important
factor for their QOL whereas other variables were weighted more heavily. According to De
Maeyer et al. (2009) substance (ab)users primarily associate social inclusion and self-
determination with QOL, and not health.
4. Strengths and limitations
When interpreting the results, some limitations must be taken into account. This study
consists of self-selected participants, and the sample may therefore not be representative
of OMT patients in general. However, substance abusers’ self-reports are regarded as gen-
erally accurate (Kopak, Proctor, & Hoffmann, 2017; Reinert & Allen, 2007; Robinson, Sobell,
Sobell, & Leo, 2014).
There are several potential explanations for the small sample size in this study. One
explanation is that life was too chaotic and not compatible with participation in this research
project. OMT patients rather needed time to arrange for a place to stay, to settle the
economy, attend meetings with their doctor, social services and other official helping ser-
vices. This was “a full time job” and they did not have the surplus at that time that was
needed to participate in this research project. Another explanation is the way patients were
recruited. The first year, participants were mainly recruited by the means of OMT advisors
working at the OMT units who informed newly enrolled patients about the study. Besides, an
information leaflet and an invitation to participate were sent to all first time enrolled
patients. This proved to be ineffective. Hence, more proactive strategy was chosen in
the second recruitment stage, with a better outcome.
Participants assessment of QOL may be influenced by their current mood (Pavot & Diener, 2008),
but the effects produced in a study are small compared to the stable variance in the measure
settings. Occasion-specific mood effects were not inherently important in ecological measurement
(Eid & Diener, 2004).
To grasp the full scope of change in OMT patients’ QOL, a follow-up period of 12 months may be
too short. According to clinical experience patients are going through many changes in life during
the first 12 months in treatment, such as getting a structured meaningful everyday life, regain
control over mental, social, economic and environmental issues that emerges after years of
substance abuse. QOL changes over time, and in a 12 month period we might just capture
temporary changes in QOL. With patients staying in OMT for years or even forever, research
needs to focus on QOL in long-term conditions. Thereby we might identify important predictors
of lasting improved QOL.
The uniqueness of our study is the frequency of the follow-up, every third month. A time interval
of three months enables participants to recall important events that affect them, in contrast to
studies with annual or longer recall periods, because recall deteriorates with time (Fadnes, Taube,
& Tylleskar, 2009).
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5. Implications of the study
Themain objective of this studywas to take a social perspective on factors that affect the quality of life of
OMT patients. Although the QOL perspective provides amore comprehensive understanding of patients’
experienceswith OMT, QOL used to be neglected in SUD studies. An important implication of this study is
that social aspects can improve QOL in OMT patients. These aspects need to be addressed in clinical
practice in a larger OMT population. By integrating QOL in clinical practices, additional information, aside
fromthediagnostic information, canbeprovided for a total picture of thepatient, and the concept ofQOL
cangobeyond theboundaries of the research field (DeMaeyer et al., 2010). It appears that the treatment
system would benefit if more attention were given to QOL factors rather than merely health issues.
Improved QOL of OMT patients may have positive effects on other issues in life.
6. Conclusion
Participants QOL vary, in terms of both overall QOL and domain-specific QOL, at enrolment in OMT and
throughout the 12-month follow-up period. Nevertheless, patients in this study experienced a small
increase of overall QOL, and a specific significant improvement was found for financial QOL during the
first 12 months in treatment. Level of education, marital status and type of housing did not predict
overall quality of life, however, higher quality of life for leisure; housing and financial situation was
associated with higher overall QOL. It is essential to enhance aspects of life that matter to patients in
OMT, as this has important implication for better treatment outcomes. The clinical practice currently
lacks this focus, which can and should be elaborated to a greater extent than today.
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